...
首页> 外文期刊>American Journal of Nuclear Medicine and Molecular Imaging >Repeatability of FDG PET/CT metrics assessed in free breathing and deep inspiration breath hold in lung cancer patients
【24h】

Repeatability of FDG PET/CT metrics assessed in free breathing and deep inspiration breath hold in lung cancer patients

机译:在肺癌患者的自由呼吸和深吸气屏气中评估FDG PET / CT指标的可重复性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

We measured the repeatability of FDG PET/CT uptake metrics when acquiring scans in free breathing (FB) conditions compared with deep inspiration breath hold (DIBH) for locally advanced lung cancer. Twenty patients were enrolled in this prospective study. Two FDG PET/CT scans per patient were conducted few days apart and in two breathing conditions (FB and DIBH). This resulted in four scans per patient. Up to four FDG PET avid lesions per patient were contoured. The following FDG metrics were measured in all lesions and in all four scans: Standardized uptake value (SUV)peak, SUVmax, SUVmean, metabolic tumor volume (MTV) and total lesion glycolysis (TLG), based on an isocontur of 50% of SUVmax. FDG PET avid volumes were delineated by a nuclear medicine physician. The gross tumor volumes (GTV) were contoured on the corresponding CT scans. Nineteen patients were available for analysis. Test-retest standard deviations of FDG uptake metrics in FB and DIBH were: SUVpeak FB/DIBH: 16.2%/16.5%; SUVmax: 18.2%/22.1%; SUVmean: 18.3%/22.1%; TLG: 32.4%/40.5%. DIBH compared to FB resulted in higher values with mean differences in SUVmax of 12.6%, SUVpeak 4.4% and SUVmean 11.9%. MTV, TLG and GTV were all significantly smaller on day 1 in DIBH compared to FB. However, the differences between metrics under FB and DIBH were in all cases smaller than 1 SD of the day to day repeatability. FDG acquisition in DIBH does not have a clinically relevant impact on the uptake metrics and does not improve the test-retest repeatability of FDG uptake metrics in lung cancer patients.
机译:在局部呼吸晚期(FD)与深度吸气屏气(DIBH)相比,在自由呼吸(FB)条件下进行扫描时,我们测量了FDG PET / CT摄取指标的可重复性。该前瞻性研究招募了20名患者。每位患者隔几天在两种呼吸条件下(FB和DIBH)进行两次FDG PET / CT扫描。这导致每位患者进行四次扫描。每个患者最多可以轮廓化四个FDG PET狂犬病灶。在所有病变和所有四个扫描中均测量了以下FDG指标:基于SUVmax的50%等构图,标准摄取值(SUV)峰值,SUVmax,SUVmean,代谢肿瘤体积(MTV)和总病变糖酵解(TLG) 。核医学医师描绘了FDG PET狂热量。在相应的CT扫描上勾勒出总肿瘤体积(GTV)。有19位患者可供分析。 FB和DIBH中FDG摄取指标的重测标准偏差为:SUVpeak FB / DIBH:16.2%/ 16.5%; SUVmax的:18.2%/ 22.1%; SUV平均值:18.3%/ 22.1%; TLG:32.4%/ 40.5%。与FB相比,DIBH的值更高,SUVmax的平均差异为12.6%,SUVpeak的平均值为4.4%和SUVmean的平均值为11.9%。与FB相比,DIBH在第1天的MTV,TLG和GTV均显着减小。但是,在所有情况下,FB和DIBH下的指标之间的差异都小于每日重复性的1 SD。在DIBH中获取FDG不会对摄取指标产生临床相关影响,也不会提高肺癌患者FDG摄取指标的重测重复性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号